|
gptkbp:instanceOf
|
Cannabis
|
|
gptkbp:aroma
|
odorless
|
|
gptkbp:ATCCode
|
none
|
|
gptkbp:biosynthesized_from
|
cannabigerolic acid (CBGA)
|
|
gptkbp:boilingPoint
|
175–178 °C (347–352 °F)
|
|
gptkbp:CASNumber
|
5957-75-5
|
|
gptkbp:chemicalFormula
|
C21H30O2
|
|
gptkbp:color
|
colorless to pale amber
|
|
gptkbp:convertedTo
|
Delta-9-THC (by isomerization)
|
|
gptkbp:discoveredBy
|
gptkb:Roger_Adams
|
|
gptkbp:effect
|
relaxation
euphoria
altered perception
|
|
gptkbp:eliminationHalfLife
|
unknown
|
|
gptkbp:firstIsolatedFrom
|
1941
|
|
gptkbp:flavor
|
slightly bitter
|
|
gptkbp:foundIn
|
Cannabis
|
|
gptkbp:hasSMILES
|
CCCCC1=CC2=C(C=C1)OC(C3=C2C(=CC(=C3)O)C)(C)C
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Delta-8-THC
|
|
gptkbp:isomerOf
|
gptkb:Delta-9-THC
|
|
gptkbp:IUPACName
|
gptkb:(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol
|
|
gptkbp:legalStatus
|
varies by jurisdiction
|
|
gptkbp:marketedAs
|
legal high (in some regions)
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
314.46 g/mol
|
|
gptkbp:psychoactive
|
true
|
|
gptkbp:PubChem_CID
|
2977
2869
CHEMBL2110636
|
|
gptkbp:relatedTo
|
gptkb:THCV
gptkb:Delta-10-THC
gptkb:CBD
|
|
gptkbp:riskFactor
|
adverse effects
contaminants in unregulated products
unknown long-term safety
|
|
gptkbp:routeOfAdministration
|
oral
inhalation
sublingual
|
|
gptkbp:solubility
|
lipid-soluble
|
|
gptkbp:source
|
hemp
marijuana
|
|
gptkbp:status
|
Schedule I (US, federal, if synthetic)
|
|
gptkbp:subject
|
state regulations (US)
DEA regulations (US)
FDA warnings (US)
|
|
gptkbp:UNII
|
6F6A27M71W
|
|
gptkbp:usedFor
|
recreational purposes
potential medical uses
|
|
gptkbp:bfsParent
|
gptkb:Δ8-THC
gptkb:Delta-10-THC
gptkb:Delta-9-THC
gptkb:Tetrahydrocannabinol
|
|
gptkbp:bfsLayer
|
7
|